Skip to content
DIVINHEALSimplifying Global Wellbeing
HOME
TREATMENTS
HOSPITALS
Page background

Targeted Molecular Therapy Success Rate in Hyderabad

Content updated at: February 19, 2026

About

Targeted Molecular Therapy Success Rates in Hyderabad

Understanding the Targeted Molecular Therapy success rate in Hyderabad is crucial for individuals navigating complex treatment paths. Outcomes for this advanced therapy depend significantly on various factors, including the specific condition being treated, the chosen therapeutic approach, and individual patient characteristics. Hyderabad has emerged as a key destination for advanced medical care, with its outcomes being subject to careful clinical review.

Healthcare providers in Hyderabad regularly assess and compare Targeted Molecular Therapy outcomes using aggregated clinical data and treatment-level evaluations. These success rates can vary based on the stage of the disease, the patient's overall health profile, and the precise molecular targets identified for intervention. Maintaining a neutral, data-driven perspective is essential for accurate insights.

Understanding Targeted Molecular Therapy Outcomes

For Targeted Molecular Therapy, 'success' typically encompasses several outcomes, ranging from disease stabilization and tumor regression to achieving complete remission. It can also signify significant improvement in quality of life or extended progression-free survival. Differentiating between short-term responses, like initial tumor shrinkage, and long-term recovery, which includes sustained control or remission, is vital for a comprehensive understanding of treatment efficacy.

Targeted Molecular Therapy Success Rate Breakdown

Success rates for Targeted Molecular Therapy vary depending on the specific approach and patient factors.

Treatment Type / Category Typical Use Case Success Rate Range (%) What Success Indicates
Early Stage Cancers with Target Treating localized tumors with specific genetic mutations. 60%–85% Significant tumor reduction or disease control.
Advanced/Metastatic Cancers with Target Managing widespread disease in patients with identified targets. 35%–60% Slowing of disease progression, improved progression-free survival.
Hematological Malignancies with Target Treating blood cancers responsive to targeted agents. 70%–90% Achieving complete or partial remission.
Tumors with Acquired Resistance Addressing disease progression after initial targeted therapy response. 20%–40% Temporary disease stabilization or modest response.

Stage-Wise and Age-Wise Targeted Molecular Therapy Survival Rate in Hyderabad

Age Group / Patient Category Disease Stage Success Rate Range (%)
Younger Adults (< 60 years) Early Stage 70%–95%
Younger Adults (< 60 years) Advanced Stage 40%–65%
Older Adults (60-75 years) Early Stage 60%–80%
Older Adults (60-75 years) Advanced Stage 30%–55%
Elderly (> 75 years) All Stages (considering comorbidities) 25%–50%

Targeted Molecular Therapy Outcomes: Hyderabad vs. Global Rates

The Targeted Molecular Therapy survival rate in Hyderabad is largely comparable with international standards, particularly when similar treatment protocols, advanced diagnostic technologies, and careful patient selection criteria are applied. India's leading medical centers maintain high clinical standards.

Country Treatment Success Rate Range (%)
India (Hyderabad) 50%–75%
USA 55%–80%
UK 50%–75%
Germany 55%–78%
Singapore 50%–75%
Thailand 45%–70%
UAE 48%–72%

These ranges are indicative, reflecting variations due to individual patient conditions and specific treatment approaches. Actual outcomes can differ significantly.

Factors Influencing Targeted Molecular Therapy Recovery Rate in Hyderabad

  • Specific genetic mutations or molecular targets identified in the tumor.
  • Stage and aggressive nature of the disease at the time of diagnosis.
  • Patient's overall health, age, and presence of any co-existing medical conditions.
  • Timeliness of diagnosis and prompt initiation of appropriate therapy.
  • Prior treatments received and the potential development of treatment resistance.
  • Adherence to the prescribed treatment regimen and regular medical monitoring.

Data Sources and Outcome Measurement

  • National cancer registries and comprehensive institutional databases.
  • Peer-reviewed scientific literature and results from rigorously conducted clinical trials.
  • Aggregated outcome data collected from multi-hospital networks and research consortia.
  • Established guidelines and recommendations published by international oncology organizations.

Informed Healthcare Choices

Making confident decisions regarding Targeted Molecular Therapy outcomes requires understanding these complex factors. Consulting specialists ensures personalized information tailored to your unique health profile and treatment goals.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Aditya Gupta

Dr. Aditya Gupta

Chairperson - Neurosurgery & CNS Radiosurgery & Co-Chief - Cyberknife Centre, Artemis Hospitals, Gurgaon

Neurosurgeon

Haryana

32+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Vivek Barun

Dr. Vivek Barun

Sr. Consultant-Neurology & Epilepsy

Neurology & Epilepsy

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Anjali Vaish

Dr. Anjali Vaish

Consultant - Physiotherapy and Rehabilitation Centre

Physiotherapy and Rehabilitation Centre

New Delhi

10+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Deepa Goel

Dr. Deepa Goel

Head Unit II

Pathology

New Delhi

21+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Tariq Matin

Dr. Tariq Matin

Director & Chief

Neurointerventional Surgery

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Meenal Thakral

Dr. Meenal Thakral

Attending Consultant – Geriatric Medicine

Geriatric Medicine, Geriatric Surgery

New Delhi

3+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Mohit Anand

Dr. Mohit Anand

Consultant - Neurology & Movement Disorders

Neurology

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Mukesh Kumar

Dr. Mukesh Kumar

Additional Consultant - Neuro Interventional Surgery

Neurointerventional Surgery

New Delhi

20+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Nitin Goel

Dr. Nitin Goel

Sr. Consultant

Paediatric Surgery

New Delhi

10+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Noaline Sinha

Dr. Noaline Sinha

Chairperson - Nuclear Medicine & Radio-Theranostics

Nuclear Medicine

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details

Related Links

Ready To Start Your Healing Journey?

Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.